GLP

R&D

New lay summary guidelines walk sponsors through their obligations under EU regulation No. 536/2014, due to come into force in February next year.

News

Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.